The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: An in vitro study

被引:151
作者
Kannan, RY
Salacinski, HJ
Odlyha, M
Butler, PE
Seifalian, AM
机构
[1] UCL, BTEC, Acad Div Surg & Intervent Sci, London NW3 2PF, England
[2] Univ London, Birkbeck Coll, Dept Chem Mat, London, England
[3] Royal Free Hosp Hampstead NHS Trust, Dept Plast & Reconstruct Surg, London NW3 2QG, England
基金
英国工程与自然科学研究理事会;
关键词
polymer; degradative; medical devices; tissue engineering; bypass graft;
D O I
10.1016/j.biomaterials.2005.10.006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Polymer biostability is one of the critical parameters by which these materials are selected for use as biomedical devices. This is the major rationale for the use of polymers which are highly crystalline and stiff namely expanded polytetrafluoroethylene (ePTFE) and Dacron in particular, as arterial bypass grafts. While this is immaterial in high-flow states, it becomes critically important at lower flows with a greater need for more compliant vessels. Polyurethanes being one of the most compliant polymers known are as such, the natural choice to build Such constructs. However, concerns regarding their resistance to degradation have limited their use as vascular prostheses and in order to augment their strength, herein a novel polyhedral oligomeric silsesquioxane integrated poly(carbonate-urea)urethane (POSS-PCU) nanocomposite was synthesised by our group. In the following series of experiments, the POSS-PCU nanocomposite samples were exposed to accelerated degradative solutions, in an 'in-house' established model in vitro for tip to 70 days before being subjected to infra-red spectroscopy, scanning electron microscopy, stress-strain studies and differential scanning calorimetry. Our results demonstrate that these silsesquioxane nanocores shield the soft segment(s) of the polyurethane, responsible for its compliance and elasticity from all forms of degradation, principally oxidation and hydrolysis. These nanocomposites hence provide an optimal method by which these polymers may be strengthened whilst maintaining their elasticity.. making them ideal as vascular prostheses particularly at low flow states. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1971 / 1979
页数:9
相关论文
共 41 条
  • [1] The use of hyaluronan and its sulphated derivative patterned with micrometric scale on glass substrate in melanocyte cell behaviour
    Barbucci, R
    Magnani, A
    Lamponi, S
    Pasqui, D
    Bryan, S
    [J]. BIOMATERIALS, 2003, 24 (06) : 915 - 926
  • [2] Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
  • [3] COURY AJ, 1996, CHEM BIOCH DEGRADATI, P243
  • [4] Eberhart A, 1999, J BIOMED MATER RES, V48, P546, DOI 10.1002/(SICI)1097-4636(1999)48:4<546::AID-JBM22>3.3.CO
  • [5] 2-M
  • [6] In vitro and in vivo biodurability of a compliant microporous vascular graft
    Edwards, A
    Carson, RJ
    Szycher, M
    Bowald, S
    [J]. JOURNAL OF BIOMATERIALS APPLICATIONS, 1998, 13 (01) : 23 - 45
  • [7] Materials become insensitive to flaws at nanoscale:: Lessons from nature
    Gao, HJ
    Ji, BH
    Jäger, IL
    Arzt, E
    Fratzl, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 5597 - 5600
  • [8] Gunatillake P.A., 2001, BIOMEDICAL APPL POLY, P160
  • [9] Comparative in vitro evaluation of two different preparations of small diameter polyurethane vascular grafts
    Hsu, SH
    Tseng, HJ
    Wu, MS
    [J]. ARTIFICIAL ORGANS, 2000, 24 (02) : 119 - 128
  • [10] Surface modification of poly(dimethylsiloxane) microfluidic devices by ultraviolet polymer grafting
    Hu, SW
    Ren, XQ
    Bachman, M
    Sims, CE
    Li, GP
    Allbritton, N
    [J]. ANALYTICAL CHEMISTRY, 2002, 74 (16) : 4117 - 4123